Cardiomyopathy Gene Panel Test
Test Name: Cardiomyopathy Gene Panel Test
Components: Sterile container/ Sterile Normal Saline Container/ EDTA Vacutainer
Price: 7200.0 AED
Sample Condition: Amniotic fluid/ Chorionic villi/ Peripheral blood
Report Delivery: 4-6 weeks
Method: NGS (Next Generation Sequencing)
Test Type: Genetics
Doctor: General Physician
Test Department:
Pre Test Information: Cardiomyopathy Gene Panel can be done with a Doctor’s prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.
Test Details:
A cardiomyopathy gene panel is a genetic test that analyzes a group of genes associated with various types of cardiomyopathy. Cardiomyopathy is a disease of the heart muscle that can lead to heart failure, arrhythmias, and sudden cardiac death.
The gene panel test can identify mutations or variants in genes that are known to cause or increase the risk of developing cardiomyopathy. This information can be used to diagnose the disease, assess the risk of developing it, and guide treatment decisions.
The genes typically included in a cardiomyopathy gene panel vary depending on the specific type of cardiomyopathy being tested for.
Test Name | Cardiomyopathy Gene Panel Test |
---|---|
Components | Sterile container/ Sterile Normal Saline Container/ EDTA Vacutainer |
Price | 7200.0 AED |
Sample Condition | Amniotic fluid\/ Chorionic villi\/ Peripheral blood |
Report Delivery | 4-6 weeks |
Method | NGS |
Test type | Genetics |
Doctor | General Physician |
Test Department: | |
Pre Test Information | Cardiomyopathy Gene Panel can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad. |
Test Details | A cardiomyopathy gene panel is a genetic test that analyzes a group of genes associated with various types of cardiomyopathy. Cardiomyopathy is a disease of the heart muscle that can lead to heart failure, arrhythmias, and sudden cardiac death. The gene panel test can identify mutations or variants in genes that are known to cause or increase the risk of developing cardiomyopathy. This information can be used to diagnose the disease, assess the risk of developing it, and guide treatment decisions. The genes typically included in a cardiomyopathy gene panel vary depending on the specific type of cardiomyopathy being tested for. |